What does biomedical — restructuring charges mean?

The actual costs recognized in the current period for restructuring the Biomedical business.

How do you interpret biomedical — restructuring charges?

High charges indicate aggressive cost-cutting or organizational shifts, which may temporarily depress segment margins.

How does biomedical — restructuring charges compare across companies?

Standard non-recurring expense reporting for companies undergoing operational restructuring.

Chart Industries GTLS Biomedical — Restructuring Charges

Discontinued — last reported Q3 '17

Similar metrics at other companies

TEC

TECHCorporate — Restructuring Charges

$688K+136%

TEC

TECHDiagnostics And Genomics — Restructuring Charges

$14K—

MOG.BMedical Devices — Restructuring Charges

$0—

IRMedical — Restructuring Charges

$1.73M-38.4%

STEHealthcare Member — Restructuring Charges

$33.82M—

BIO.BLife Science — Restructuring Charges

——

Other financials

Income statement

See full

Revenue$884.8M-11.7%

Gross profit$251.4M-26.0%

Operating income$52.6M-65.5%

Net income-$17.1M-135%

EPS (diluted)-$0.36-138%

Balance sheet

See full

Cash & equivalents$269.4M-9.6%

Total debt$3.9B+1.9%

Total equity$3.2B+5.3%

Total assets$9.7B+4.1%

Cash flow

See full

Operating cash flow-$248.0M-313%

CapEx$24.8M+23.4%

Free cash flow-$272.8M-241%

Valuation

See full

Market cap$9.96B+50.0%

Enterprise value$13.59B+33.6%

P/S2.4×+0.8×

Profitability

See full

Gross margin32.5%-1.3pp

Operating margin6.2%-10.1pp

Net margin-0.6%-6.7pp

FCF margin0.2%-10.3pp

Returns & leverage

See full

Return on equity-0.8%-9.8pp

Debt / equity1.2×0.0×

Current ratio1.5×0.0×

Where this comes from

Reported directly by Chart Industries in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Chart Industries’s 10-Q, filed October 26, 2017, on SEC EDGAR. View the filing →

Questions, answered.

What does biomedical — restructuring charges mean?: The actual costs recognized in the current period for restructuring the Biomedical business.
How do you interpret biomedical — restructuring charges?: High charges indicate aggressive cost-cutting or organizational shifts, which may temporarily depress segment margins.
How does biomedical — restructuring charges compare across companies?: Standard non-recurring expense reporting for companies undergoing operational restructuring.